Market: NASD |
Currency: USD
Address: 11555 Sorrento Valley Road
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
📈 Aethlon Medical, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$3.03
-
Upside/Downside from Analyst Target:
90.25%
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2025-11-13
-
EPS Estimate:
-0.40
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.125000 |
- |
2025-06-09 |
- |
Stock split |
|
Total Amount for 2025: $0.125000 |
| 2023 |
- |
$0.100000 |
- |
2023-10-05 |
- |
Stock split |
|
Total Amount for 2023: $0.100000 |
| 2019 |
- |
$0.066667 |
- |
2019-10-15 |
- |
Stock split |
|
Total Amount for 2019: $0.066667 |
| 2015 |
- |
$0.020000 |
- |
2015-04-14 |
- |
Stock split |
|
Total Amount for 2015: $0.020000 |
📅 Earnings & EPS History for Aethlon Medical, Inc.
| Date | Reported EPS |
|---|
| 2025-11-12 (estimated upcoming) | - |
| 2025-08-13 | -0.85 |
| 2025-06-26 | -3.7 |
| 2025-02-12 | -1.04 |
| 2024-11-13 | -1.6 |
| 2024-08-14 | -2.72 |
| 2024-06-27 | -7.28 |
| 2024-02-14 | -10.96 |
| 2023-11-14 | -9.76 |
| 2023-08-10 | -11.2 |
| 2023-06-28 | -8.8 |
| 2023-02-13 | -9.6 |
| 2022-11-14 | -14.4 |
| 2022-08-09 | -15.2 |
| 2022-06-28 | -20 |
| 2022-02-14 | -12.8 |
| 2021-11-09 | -10.4 |
| 2021-08-09 | -12.8 |
| 2021-06-24 | -12 |
| 2021-02-10 | -16 |
| 2020-10-28 | -12 |
| 2020-06-25 | 44.2 |
| 2020-02-10 | -24.24 |
| 2019-11-01 | -103.27 |
| 2019-08-14 | -101.98 |
📰 Related News & Research
No related articles found for "aethlon medical".
